This guide examines the scientific rationale for combining the two peptides, summarizes what the preclinical literature does and does not demonstrate, and outlines the safety and regulatory context
They accentuate healing
That rules out, straightforwardly, radioligand or fluorescent binding assays, competition binding against a known ligand, recombinant receptor-expressing lines, functional readouts tied to a defined coupling pathway, and antagonist controls to demonstrate that an effect is receptor-mediated
This extensive distribution, combined with rapid plasma clearance, suggests tissue binding or cellular uptake contributes to the peptide's pharmacological effects
Site rotation (abdomen, thighs, upper arms) is the commonly reported approach to reduce this reaction